It wasnt until 2021 that Wegovy, another GLP-1 (glucagon-like peptide receptor agonist) was approved specifically for weight loss
In parallel, microbiota-modified bile acids activate the farnesoid X receptor (FXR) and Takeda G-protein-coupled receptor 5 (TGR5), regulating hepatic lipid metabolism and enhancing adipose thermogenesis
Required documentation typically includes the prescription, two years of relevant medical records, prior weight-loss attempt history, lab values (lipid panel, A1c, CMP), and any comorbidity workup (sleep study for OSA indication, CV imaging for SELECT indication)
Phase 2 trials - secondary measures Phase 3 results (pending) TRIUMPH and TRANSCEND are the large Phase 3 programmes asking the longer-term safety and outcome questions
Photo Credit: Baldwin Publishing Staff Photographer 20 mins This warm, savory bowl blends fiber-rich oats with protein-packed eggs for lasting satisfaction